EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study on Contrast-Enhanced Ultrasound Imaging and Anti-Tumor Effects of Drug-Loaded Nanodroplets with Tumor Targeting and Ultrasound Sensitivity

Yaqiong Li, Yongqing Chen, Ruiqing Liu, Shaobo Duan, Lijuan Chen, Jun Sun, Lianzhong Zhang

Frontiers in Bioscience-Landmark · 2023

DOI: 10.31083/j.fbl2806115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Yaqiong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, 450003 …. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Breakthrough Project of Henan Province, Key Research and Development Project of Henan Province, Science and Technology Project of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ultrasound-responsive nanodroplets (NDs) targeting tumors have shown great potential in ultrasound imaging and tumor therapy, but most of these studies are based NDs with lipid shells that cannot overcome the uptake by cells of the reticulo-endothelial system (RES). NDs with shells comprised of polyethylene glycol (PEG)-based polymers could effectively suppressed the uptake of RES, but the phase transition, contrast-enhanced imaging and drug release about these NDs have not been well illuminated.

Methods

Folate receptor targeted NDs with shells of polymers and loaded with DOX (FA-NDs/DOX) were prepared. The particle size distribution and morphology of NDs was characterized with dynamic light scattering (DLS) and microscope. Phase transition and contrast-enhanced ultrasound imaging under different mechanical indices (MIs) was studied, and the intensity of contrast enhancement were quantitatively analyzed. The targeting property of FA-NDs/DOX to MDA-MB-231 cells and cellular uptake were observed using a fluorescence microscope. The anti-tumor effects of FA-NDs/DOX combined with low-intensity focused ultrasound (LIFU) was studied through cytotoxicity tests. Flow cytometry assays were used to detect cell apoptosis.

Results

The average particle size of the FA-NDs/DOX was 448.0 ± 8.9 nm, and the zeta potential was 30.4 ± 0.3 mV. When exposed to ultrasound at 37 °C, ultrasound contrast enhancement of FA-NDs/DOX was observed when MI ≥0.19. A stronger acoustic signal was observed under higher MIs and concentrations. The results of quantitative analysis showed that the contrast enhancement intensity of FA-NDs/DOX (1.5 mg/mL) at MI of 0.19, 0.29 and 0.48 was 26.6 ± 0.9 dB, 97.0 ± 3.8 dB and 153.1 ± 5.7 dB, respectively. The contrast enhancement of the FA-NDs/DOX lasted for more than 30 minutes at an MI of 0.48. In targeting experiments, FA-NDs could be recognized by MDA-MB-231 cells, and significant cellular uptake was observed. The blank FA-NDs showed good biocompatibility, while the FA-NDs/DOX induced apoptosis of MDA-MB-231 and MCF-7 cells. By combining LIFU irradiation and FA-NDs/DOX treatment, the best cell-killing effect was achieved.

Conclusions

The FA-NDs/DOX prepared in this study has excellent performance in contrast-enhanced ultrasound imaging, tumor targeting and enhanced chemotherapy. This FA-NDs/DOX with polymer shells provides a novel platform for ultrasound molecular imaging and tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesHumansUltrasonographyPolyethylene GlycolsPolymersPhase TransitionCell Line, TumorFolic Acid

Stichwörter der Autor:innen

phase transitionpolymeric nanodropletstumor targetingtumor therapyultrasound imaging

Substanzen

Polyethylene GlycolsPolymersFolic Acid

Autor:innen und Institutionen

  • Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, 450003 Zhengzhou, Henan, China.
  • Department of Ultrasound, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, 450003 Zhengzhou, Henan, China.
  • Henan Engineering Technology Research Centre of Ultrasonic Molecular Imaging and Nanotechnology, 450003 Zhengzhou, Henan, China.
  • Department of Medical Imaging, Henan Provincial People's Hospital & the People's Hospital of Zhengzhou University, 450003 Zhengzhou, Henan, China.

Förderung

  • Medical Science and Technology Breakthrough Project of Henan Province
  • Key Research and Development Project of Henan Province
  • Science and Technology Project of Henan Province
  • Natural Science Foundation of He’nan Province

Zitieren

APA

Li, Y., Chen, Y., Liu, R., Duan, S., Chen, L., Sun, J., & Zhang, L. (2023). Study on Contrast-Enhanced Ultrasound Imaging and Anti-Tumor Effects of Drug-Loaded Nanodroplets with Tumor Targeting and Ultrasound Sensitivity. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2806115

Vancouver

Li Y, Chen Y, Liu R, Duan S, Chen L, Sun J, et al. Study on Contrast-Enhanced Ultrasound Imaging and Anti-Tumor Effects of Drug-Loaded Nanodroplets with Tumor Targeting and Ultrasound Sensitivity. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2806115

BibTeX
@article{Li2023,
  author = {Li, Yaqiong and Chen, Yongqing and Liu, Ruiqing and Duan, Shaobo and Chen, Lijuan and Sun, Jun and Zhang, Lianzhong},
  title = {Study on Contrast-Enhanced Ultrasound Imaging and Anti-Tumor Effects of Drug-Loaded Nanodroplets with Tumor Targeting and Ultrasound Sensitivity},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2023},
  doi = {10.31083/j.fbl2806115}
}
Kostenlos starten →